Have a personal or library account? Click to login
Colitis due to cancer treatment with immune check-point inhibitors – review of literature and presentation of clinical cases Cover

Colitis due to cancer treatment with immune check-point inhibitors – review of literature and presentation of clinical cases

Radiology and Oncology
Volume 58 (2024): Issue 2 (June 2024)
By: Andreja Ocepek  
Open Access
|Mar 2024

Authors

Andreja Ocepek

andreja.ocepek@ukc-mb.si

Department of Gastroenterology, Division of Internal Medicine, University Medical Centre Maribor, Maribor, Slovenia
DOI: https://doi.org/10.2478/raon-2024-0022 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 179 - 185
Submitted on: Aug 10, 2023
|
Accepted on: Jan 29, 2024
|
Published on: Mar 22, 2024
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
immune checkpoint inhibitors,
immune checkpoint inhibitors induced colitis,
immune-mediated microscopic colitis,
corticosteroid therapy,
infliximab,
vedolizumab
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2024 Andreja Ocepek, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 58 (2024): Issue 2 (June 2024)Next article